Clinical Trials
18 trialsNCT03893539 2024-03-29
Clinical Utility for Ion Endoluminal System
Intuitive Surgical
Phase NA Unknown
NCT02871856 2023-12-05
ILST
The University of Queensland
Phase NA Unknown
NCT05899270 2023-06-12
3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial
Sichuan Cancer Hospital and Research Institute
Phase NA Unknown
NCT03085069 2023-02-16
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT05308771 2022-04-04
To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery
Centre Hospitalier Universitaire de Tivoli
Phase NA Unknown
NCT05299385 2022-03-29
The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)
Lifesemantics Corp.
Phase 3 Unknown
NCT05230563 2022-02-09
A Clinical Study of LUNG-CT CAD Decision Support
TaiHao Medical Inc.
Phase NA Unknown
NCT03937583 2021-12-09
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4 Unknown
NCT05077111 2021-10-14
VATS
Ain Shams University
Phase 4 Unknown
NCT04982042 2021-08-04
COVID19REHAB
Centro Universitário de Anapolis
Phase NA Unknown
NCT04725448 2021-04-06
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03402048 2020-11-04
EPIC
University of Turin, Italy
Phase 3 Unknown
NCT04371796 2020-05-01
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT04133337 2019-10-21
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1/2 Unknown
NCT03389256 2018-01-03
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03083743 2017-03-20
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Shanghai Gebaide Biotechnology Co., Ltd.
Phase 3 Unknown
NCT01944813 2014-12-23
Advance Care Planning: A Way to Improve End-of-life Care Life Care
University of Aarhus
Phase NA Unknown